Close Menu

genome analysis

Michigan-based Advaita Bioinformatics wants to be a one-stop shop for proteomics, transcriptomics, and variant analysis, as well as internet omics search.

The companies will pair sequencing with genotype-phenotype matching and analytics in pursuit of wider access to precision medicine and faster, more accurate diagnoses.

The two Netherlands-based firms will market their joint offering to pharmaceutical companies and others researching immune system-related diseases.

The new funding brings the Series B total to £23.3 million for the British clinical decision support technology developer.

The informatics firms signed agreements to offer certain of their genomic data technologies on Google's cloud-based computing services platform.

LifeMap says that the newly announced partnership will improve literature searches for users of its GeneCards knowledge base and TGex clinical genomics platform.

The Common Infrastructure for National Cohorts in Europe, Canada, and Africa (CINECA) project looks to harmonize ontologies and create an interoperability platform for global genomics research.

Taiwanese startup Atgenomix and Yourgene Bioscience Taiwan are combining technologies to build a "comprehensive" system for WGS and WES variant analysis.

The R&D collaboration will examine a Western Digital theory that moving computational power closer to large genomic datasets can speed up analysis.

At the PAG conference, researchers said they are sequencing 100 tomato genomes in 100 days using Oxford Nanopore's PromethIon and a pipeline for maximizing SV diversity.

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.